$NVP #NeuroVive Pharmaceutical AB Abliva - New strategic investor on board and CMD: The rights issue announced on 19 February 2020 is now complete with 90% of the total amount of offered shares subscribed raising a total SEK67m. A… https://t.co/0CTGKzt3YW #equity #stocks